Display options
Share it on

J Cardiovasc Dis Res. 2013 Mar;4(1):20-4. doi: 10.1016/j.jcdr.2013.02.013. Epub 2013 Feb 27.

Effect of omega-3 on brain natriuretic peptide and echocardiographic findings in heart failure: Double-blind placebo-controlled randomized trial.

Journal of cardiovascular disease research

J Kojuri, M A Ostovan, G R Rezaian, P Archin Dialameh, N Zamiri, M B Sharifkazemi, M Jannati

Affiliations

  1. Cardiology Department, Shiraz University of Medical Sciences, Shiraz, Iran ; Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

PMID: 24023466 PMCID: PMC3758087 DOI: 10.1016/j.jcdr.2013.02.013

Abstract

BACKGROUND: Possible beneficial effects of dietary omega-3 supplementation on patients with congestive heart failure (CHF) were investigated.

METHODS AND RESULTS: 100 patients with CHF who had a tri-chamber pacemaker and automated defibrillator were initially recruited, and 70 agreed to participate.38 patients received 2 g/day of omega-3 and 32 received placebo capsules. BNP level, 6-min walk test and echocardiographic parameters were recorded at baseline and after 6 months of treatment. BNP levels decreased significantly after 6 months in the omega-3 group, from 1766.2 ± 1978.1 pg/mL to 1159.4 ± 1430.9 pg/dL (P < 0.005). Tei index and late diastolic velocity index were significantly improved in treated group. Mortality and hospitalization rates did not differ.

CONCLUSION: The beneficial effects of omega-3 supplementation in patients with CHF were not as clear as hypothesized; however, omega-3 fatty acids can result in small changes in plasma BNP levels and modest improvements in echocardiographically assessed diastolic function (Clinical trial.gov registration: NCT01227837).

Keywords: Brain natriuretic peptide; Congestive; Heart failure; Omega-3

References

  1. Clin Med (Lond). 2004 Jan-Feb;4(1):18-22 - PubMed
  2. BMJ. 2010 Mar 23;340:c332 - PubMed
  3. Am J Pathol. 2006 Dec;169(6):1913-24 - PubMed
  4. Eur J Cardiovasc Prev Rehabil. 2004 Aug;11(4):267-74 - PubMed
  5. Lancet. 2008 Oct 4;372(9645):1223-30 - PubMed
  6. J Int Med Res. 2009 Nov-Dec;37(6):1831-41 - PubMed
  7. N Engl J Med. 2003 May 15;348(20):2007-18 - PubMed
  8. Prog Cardiovasc Nurs. 2009 Sep;24(3):113-4 - PubMed
  9. J Mol Cell Cardiol. 2006 Nov;41(5):914-7 - PubMed
  10. J Am Coll Cardiol. 2001 Aug;38(2):436-42 - PubMed
  11. J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):6A-13A - PubMed
  12. Circulation. 2008 Jan 29;117(4):536-44 - PubMed
  13. Circulation. 2003 Mar 11;107(9):1278-83 - PubMed
  14. Pol Arch Med Wewn. 2009 Mar;119(3):162-9 - PubMed
  15. Europace. 2009 Nov;11 Suppl 5:v1-9 - PubMed
  16. Curr Atheroscler Rep. 2009 Nov;11(6):440-7 - PubMed
  17. Curr Vasc Pharmacol. 2004 Jan;2(1):45-52 - PubMed
  18. N Engl J Med. 1987 Jun 4;316(23):1429-35 - PubMed
  19. J Am Coll Cardiol. 2004 May 5;43(9):1584-9 - PubMed
  20. Cardiovasc Res. 2009 Oct 1;84(1):33-41 - PubMed
  21. Circulation. 2002 May 21;105(20):2392-7 - PubMed
  22. Clin Chem. 1993 May;39(5):825-32 - PubMed
  23. Am Heart J. 2009 Aug;158(2):163-169.e1-3 - PubMed
  24. JAMA. 2006 Jun 14;295(22):2613-9 - PubMed
  25. J Am Coll Cardiol. 2001 Dec;38(7):1934-41 - PubMed
  26. J Heart Lung Transplant. 2006 Jul;25(7):834-8 - PubMed
  27. Am Heart J. 2008 Nov;156(5):965-74 - PubMed

Publication Types